Some Thoughts About Warfarin and NOACS
Main Author: | C. Richard Conti |
---|---|
Format: | Article |
Language: | English |
Published: |
Compuscript Ltd
2017-01-01
|
Series: | Cardiovascular Innovations and Applications |
Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2016.0049 |
Similar Items
-
Warfarin involvement, in comparison to NOACs, in the development of systemic atherosclerosis
by: Romeo Gabriel Mihaila
Published: (2022-05-01) -
Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
by: Zei Li, et al.
Published: (2022-06-01) -
Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
by: Line Melgaard, et al.
Published: (2021-12-01) -
Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement.
by: Victor Chien-Chia Wu, et al.
Published: (2020-01-01) -
Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis
by: Qiyu He, et al.
Published: (2019-05-01)